Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 171
| Title | Principal Investigator | Start Year | Funding Agency | Research Area |
|---|---|---|---|---|
| Noncovalent Interactions Driven Drug Designing for Depression: A Computational Approach towards Medical Treatment of Depression | Dr. Juhi Dutta, Indian Institute Of Technology (IIT) Guwahati, Assam | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Development of in vitro and in vivo drug screening platforms against the chikungunya virus | Dr. Chetan Dewaji Meshram, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| A Multiscale Study of Photoswitchable Drugs for Optimal Control of G-Protein Coupled Receptors | Dr. Padmabati Mondal, Indian Institute of Science Education and Research (IISER) Tirupati, Andhra Pradesh | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Controlled Polymer- Insulin interaction in the Transdermal Insulin Drug Delivery system | Prof. Sudip K Pattanayek, Indian Institute Of Technology (IIT) Delhi | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Determination of In Vivo Effective Diffusion Rates of Therapeutics from Controlled Release Systems | Dr. Siddharth Jhunjhunwala, Indian Institute Of Science, Bangalore, Karnataka | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators | Dr. Ravindra Kumar, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Dual-targeted novel combination therapy for triple-negative breast cancer | Dr. Shashank Kumar, Central University Of Punjab, Bathinda, Punjab | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Water-soluble Ru(II) and Pd(II) Porphyrins as Novel Photosensitizers for Photodynamic Therapy | Dr. Tridib Kumar Goswami, Gauhati University, Assam | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| Exploration of Cyclic Diaryliodonium Salts as Biarylating Agents to Generate Medicinally Relevant Biaryl | Dr. Malleswara Rao Kuram, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |